Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68788-8367

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68788-8367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of Tramadol Hydrochloride is shown, depicting its molecular framework including the methoxyphenyl group, cyclohexanol ring, and dimethylaminoethyl side chain with associated hydrochloride salt notation.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph depicting Tramadol concentration (ng/mL) versus time (hours) comparing Tramadol Hydrochloride Extended-Release Tablets 200 mg q.d. (black circles) and Tramadol Hydrochloride Tablets 50 mg q6h (white circles). The graph shows fluctuations in plasma concentration over 24 hours for both dosage forms.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows M1 concentration.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

Line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing percent of patients achieving various levels of response threshold. The x-axis represents response threshold as percent improvement from baseline, ranging from 0 to 100%. The y-axis shows percent of patients achieving response, ranging approximately from 0 to 60%. Five lines represent Tramadol Hydrochloride extended-release tablets at 100 mg, 200 mg, 300 mg, 400 mg doses, and placebo, with higher doses generally showing greater patient response across thresholds.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line chart comparing the percent of patients achieving various levels of response threshold (percent improvement from baseline) between Tramadol Hydrochloride Extended-Release Tablets and placebo in an arthritis pain intensity study. The x-axis represents response thresholds from 0 to 100%, and the y-axis shows the percent of patients achieving response, ranging from 0 to 60%. Two lines indicate higher patient response rates for Tramadol Hydrochloride Extended-Release Tablets across most thresholds compared to placebo.*

FDA Label Image

Tramadol Hydrochloride Er Tablets 100mg (C30f6e9e 8014 40fc 9615 A6b8654137c1 00)

Label for Tramadol Hydrochloride ER Tablets 100 mg, extended-release oral tablets. The label includes dosing directions in English and Spanish for tablet count and daily frequency, storage instructions, and cautions. Manufactured by Lupin Pharmaceuticals, Inc., the label also notes this is a generic for Ultram ER and displays a barcode and QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.